Professor Emma Cave emma.cave@durham.ac.uk
Professor
European Union (EU) Clinical Trials Regulation 536/2014, expected to come into force in 2019, provides for a streamlined single EU application for cross-border clinical trials and enhanced transparency of results. The status of the Regulation in post-Brexit UK is uncertain. Matters of regulatory alignment will be covered by agreements on the future EU-UK relationship. In the short term, implementation of the Regulation in the United Kingdom depends on the Brexit model and timing of the Regulation’s implementation. The EU (Withdrawal) Act will convert EU law into UK law, including the vast array of EU life sciences regulation. However, the Regulation is likely to be implemented after the United Kingdom leaves the EU, but within the transition period. If the United Kingdom is not part of the legal framework governing clinical trials in the EU, then the United Kingdom will still need to comply with the global framework set out in the International Council on Harmonisation if it wants to be part of trials of medicinal products for which marketing authorization will be sought for licensing in the European Economic Area. This article extols the virtues of harmonization with the EU and attempts to counter some of the media focus on the advantages of a deregulated bespoke approach.
Cave, E. (2018). EU Clinical Trials Regulation 2014: Fetter or facilitator?. Medical Law International, 18(2-3), 179-194. https://doi.org/10.1177/0968533218799535
Journal Article Type | Article |
---|---|
Acceptance Date | May 23, 2018 |
Online Publication Date | Sep 9, 2018 |
Publication Date | Sep 9, 2018 |
Deposit Date | Sep 12, 2018 |
Publicly Available Date | Sep 13, 2018 |
Journal | Medical Law International |
Print ISSN | 0968-5332 |
Electronic ISSN | 2047-9441 |
Publisher | SAGE Publications |
Peer Reviewed | Peer Reviewed |
Volume | 18 |
Issue | 2-3 |
Pages | 179-194 |
DOI | https://doi.org/10.1177/0968533218799535 |
Keywords | Clinical trials, Brexit. |
Public URL | https://durham-repository.worktribe.com/output/1320097 |
Published Journal Article (Final published version)
(258 Kb)
PDF
Publisher Licence URL
http://creativecommons.org/licenses/by-nc/4.0/
Copyright Statement
Final published version
Published Journal Article (Advance online version)
(257 Kb)
PDF
Publisher Licence URL
http://creativecommons.org/licenses/by-nc/4.0/
Copyright Statement
Advance online version This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
Infected blood scandal – what you need to know
(2024)
Newspaper / Magazine
A Future Orientated View of Autonomy
(2023)
Book Chapter
The Warnock Report on Human Fertilisation and Embryology (1984)
(2023)
Book Chapter
Medicine, Patients and the Law
(2023)
Book
About Durham Research Online (DRO)
Administrator e-mail: dro.admin@durham.ac.uk
This application uses the following open-source libraries:
Apache License Version 2.0 (http://www.apache.org/licenses/)
Apache License Version 2.0 (http://www.apache.org/licenses/)
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2025
Advanced Search